Replies to post #88668 on Innovation Pharmaceuticals Inc (IPIX)

[carpetdude]

Nice.

[Talc Moan]

Good Morning, World Good Morning, CTIX!

Fantastic news!

Everyone have a awesome day!

Regards

Smitter

[BooDog]

Thanks NR, can you edit that and put the showcase recap link at the bottom as well and I'll make yours a sticky. :-)


http://investorshub.advfn.com/boards/read_msg.aspx?message_id=109855402
showcase recap


"Okay... done."


Thanks, no biggie but I was thinking the recap is still clicked on a lot and is very beneficial.
Thanks!!!

[BooDog]

Very Big Pharma esque. Not very often (to say the least) that you see a small bio presenting at a major conference like this. And this is THREE presentations.

European Congress of Clinical Microbiology and Infectious Diseases.

Very, very, VERY cool!!!


Go Leo!AND Dr. J!!!

[John B]

Nice! Was not expecting any PR today, thanks for posting.

[Phoenix300]

Is Copenhagen, Denmark ECCMID your next field trip?

Or perhaps one of the CTIX faithful based in Europe will attend?

[thefamilyman]

If I could attend, this is the session in which I would be most interested. At this point, I feel pretty confident in Brilacidin. I want to hear more about the other products in the pipeline.

In addition to the clinical data from the ABSSSI trial, Cellceutix(CTIX) will also present important preclinical data. The abstract entitled Synthetic Novel Host Defense Protein Mimetics for the Treatment of Gram-Negative Bacterial Infections has been accepted for oral presentation in the session entitled Drug Discovery. "This is an opportunity for experts to hear about the other promising defensin-mimetics -- not just Brilacidin," said Dr. Jorgensen. "These compounds have potential to treat serious Gram-negative infections, including those identified by CDC as 'antibiotic resistance threats.' " - from the PR